One other quick thing I would note is that the only tests you really need are LDP-P, APoB, and HDL-P. If your LDL-C or total Cholesterol is high but LDL-P/ApoB are in range, I wouldn't worry. Like in the slightest. Atherogenic particle count is all that matters, basically nothing else. LDL-C will typically covary w/ -P, but sometimes not in younger, healthier people -- LDL-C is just a way cheaper and simpler test so it's given.
I really wouldn't consider statins (cholesterol is the backbone of all steriodogenesis in the body + your brain is a big ball of it). You do not want to inhibit its production. Ezetimibe and PCSK9i's are a bit less dangerous -- though the latter are presently very costly. Still pharma intervention is, a priori, very unlikely to be necessary in your case.
You really needed to include an APoB test in your panel. Lp(a) is not sufficient and is genetically determined to a significant extent.
Thanks! Appreciate that
One other quick thing I would note is that the only tests you really need are LDP-P, APoB, and HDL-P. If your LDL-C or total Cholesterol is high but LDL-P/ApoB are in range, I wouldn't worry. Like in the slightest. Atherogenic particle count is all that matters, basically nothing else. LDL-C will typically covary w/ -P, but sometimes not in younger, healthier people -- LDL-C is just a way cheaper and simpler test so it's given.
I really wouldn't consider statins (cholesterol is the backbone of all steriodogenesis in the body + your brain is a big ball of it). You do not want to inhibit its production. Ezetimibe and PCSK9i's are a bit less dangerous -- though the latter are presently very costly. Still pharma intervention is, a priori, very unlikely to be necessary in your case.